Pathology Lab Urges 8th Circ. Not To Revive Antitrust Claims

By Matthew Perlman · May 9, 2025, 10:16 PM EDT

Iowa Pathology Associates told the Eighth Circuit a lower court was right to toss a rival lab's case accusing it of monopolizing the market because the claims are really about the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Goldfinch Laboratory, P.C. v. Iowa Pathology Associates, P.C. et al

Case Number

Court

Iowa Southern

Nature of Suit

Anti-Trust

Date Filed

May 13, 2024

Case Title

Goldfinch Laboratory, P.C. v. Iowa Pathology Associates, P.C., et al

Case Number

Court

Appellate - 8th Circuit

Nature of Suit

3410 Antitrust

Date Filed

January 14, 2025

Recent Articles By Matthew

April 30, 2025
Monthly Merger Review Snapshot
April 14, 2025
Takeda Gets Actos Case Paused For Class Cert. Review
April 07, 2025
Monthly Merger Review Snapshot
April 02, 2025
Serial Acquisitions Are Still On The FTC's Radar
April 01, 2025
Takeda Antitrust Trial Over Actos Generics Set For July
March 28, 2025
PE Firm Hits Back Against Medical Device Coating Challenge
March 27, 2025
DOJ's Antitrust Unit Targeting Anticompetitive Regulations
March 20, 2025
8th Circ. Won't Pause FTC's Insulin Pricing Case
March 17, 2025
Court Won't Toss Biotech Co.'s Antitrust Counterclaim
March 14, 2025
FTC Urges 8th Circ. Not To Pause Insulin Pricing Case